$IMLFF closed up 2.72% on reversal. $IMLFF InMe
Post# of 35499
$IMLFF InMed’s proprietary in silico drug/disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company. $VBIO $GWPH $AXIM